EPIX
ESSA Pharma
EPIX
EPIX
Delisted
EPIX was delisted on the 8th of October, 2025.
10 hedge funds and large institutions have $23.6M invested in ESSA Pharma in 2016 Q4 according to their latest regulatory filings, with funds opening new positions, 3 increasing their positions, 1 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
10
Holders Change
-2
Holders Change %
-16.67%
% of All Funds
0.25%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.05%
New
–
Increased
3
Reduced
1
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
ACP
Acuta Capital Partners
Redwood City,
California
|
+$40.9K |
| 2 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$4.52K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
+$955 |
Top Sellers
| 1 |
DCM
DAFNA Capital Management
Los Angeles,
California
|
-$287K |
| 2 |
BC
Boxer Capital
San Diego,
California
|
-$74K |
| Name | Holding | Trade Value |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
EAM
1
Eventide Asset Management
Boston,
Massachusetts
| $5.26M | – | – | – |
|
|
DM
2
Deerfield Management
New York
| $4.65M | – | – | – |
|
|
CV
3
Clarus Ventures
Cambridge,
Massachusetts
| $4.64M | – | – | – |
|
|
OFM
4
Omega Fund Management
Boston,
Massachusetts
| $3.72M | – | – | – |
|
|
AIC
5
AWM Investment Company
New York
| $3.72M | – | – | – |
|
|
ACP
6
Acuta Capital Partners
Redwood City,
California
| $1.33M | +$40.9K | +930 | +3% |
|
|
DCM
7
DAFNA Capital Management
Los Angeles,
California
| $289K | -$287K | -4,873 | -50% |
|
|
8
Royal Bank of Canada
Toronto,
Ontario, Canada
| $14K | +$4.52K | +100 | +48% |
|
|
TRCT
9
Tower Research Capital (TRC)
New York
| $5K | +$955 | +21 | +24% |
|
10
Bank of Montreal
Toronto,
Ontario, Canada
| $2K | – | – | – |
|
|
BC
11
Boxer Capital
San Diego,
California
| – | -$74K | -1,405 | Closed |
|